Researchers at the Hebrew University, led by Prof. Isaiah “Shy” Arkin, Arthur Lejwa Chair in Biochemistry at the Silberman Institute for Life Sciences and former Vice President, Research and Development, have identified three existing drugs as potential treatments for COVID-19.
They placed the substances with live SARS‑CoV‑2 and human cells in vitro. The results “showed that the drugs can protect cells from onslaught by the virus with close to 100 percent effectiveness, meaning that almost 100% of the cells lived despite being infected by the virus,” Prof. Isaiah Arkin, the Hebrew University biochemist behind the research, told The Times of Israel.
Read full article here